Clinical Trials Directory

Trials / Completed

CompletedNCT02756481

Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela

Treatment Patterns of Care for Patients With Atrial Fibrillation In Venezuela

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Bristol-Myers Squibb · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To characterize treatment patterns and healthcare resource utilization among adults diagnosed with non-valvular atrial fibrillation (NVAF) from the private setting in Venezuela.

Conditions

Timeline

Start date
2013-10-01
Primary completion
2014-11-01
Completion
2014-11-01
First posted
2016-04-29
Last updated
2016-04-29

Source: ClinicalTrials.gov record NCT02756481. Inclusion in this directory is not an endorsement.